G. Rohde

746 total citations
17 papers, 621 citations indexed

About

G. Rohde is a scholar working on Atomic and Molecular Physics, and Optics, Atmospheric Science and Psychiatry and Mental health. According to data from OpenAlex, G. Rohde has authored 17 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Atomic and Molecular Physics, and Optics, 3 papers in Atmospheric Science and 3 papers in Psychiatry and Mental health. Recurrent topics in G. Rohde's work include Atmospheric chemistry and aerosols (3 papers), Sexual function and dysfunction studies (3 papers) and Computational Drug Discovery Methods (2 papers). G. Rohde is often cited by papers focused on Atmospheric chemistry and aerosols (3 papers), Sexual function and dysfunction studies (3 papers) and Computational Drug Discovery Methods (2 papers). G. Rohde collaborates with scholars based in Germany, United States and Chile. G. Rohde's co-authors include Richard Sachse, Georg Wensing, R. Horstmann, S. Unger, F. Jockenhövel, Roger Engelmann, T. Klotz, J. Pablo Huidobro‐Toro, Wolfgang Mück and Andreas Johne and has published in prestigious journals such as Chemical Physics Letters, European Urology and European Journal of Pharmacology.

In The Last Decade

G. Rohde

17 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Rohde Germany 9 209 157 103 99 96 17 621
Karin Hedenmalm Sweden 15 264 1.3× 96 0.6× 46 0.4× 80 0.8× 110 1.1× 38 913
Stephen Freestone United Kingdom 9 184 0.9× 187 1.2× 44 0.4× 395 4.0× 145 1.5× 10 850
Christopher P Alderman Australia 16 107 0.5× 25 0.2× 52 0.5× 74 0.7× 59 0.6× 65 720
Stefan Viktor Vormfelde Germany 17 46 0.2× 167 1.1× 247 2.4× 111 1.1× 131 1.4× 37 907
Tamara A. Sutfin United States 11 77 0.4× 243 1.5× 100 1.0× 77 0.8× 142 1.5× 13 728
Д. А. Сычев Russia 13 101 0.5× 53 0.3× 47 0.5× 215 2.2× 249 2.6× 283 804
Abdelilah Abouelfath France 16 52 0.2× 50 0.3× 38 0.4× 153 1.5× 35 0.4× 41 635
Emmanuelle Bondon‐Guitton France 17 98 0.5× 48 0.3× 54 0.5× 58 0.6× 73 0.8× 44 834
D S Hewick United Kingdom 11 60 0.3× 44 0.3× 91 0.9× 117 1.2× 262 2.7× 32 641
Mary Loverde United States 10 60 0.3× 48 0.3× 55 0.5× 165 1.7× 23 0.2× 13 643

Countries citing papers authored by G. Rohde

Since Specialization
Citations

This map shows the geographic impact of G. Rohde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Rohde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Rohde more than expected).

Fields of papers citing papers by G. Rohde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Rohde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Rohde. The network helps show where G. Rohde may publish in the future.

Co-authorship network of co-authors of G. Rohde

This figure shows the co-authorship network connecting the top 25 collaborators of G. Rohde. A scholar is included among the top collaborators of G. Rohde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Rohde. G. Rohde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Samama, M, G. Contant, Theodore E. Spiro, et al.. (2012). Evaluation of the antifactor XA chromogenic assay for measuring rivaroxaban plasma concentrations using calibrators and controls. European Journal of Hospital Pharmacy. 19(2). 236.3–237. 5 indexed citations
3.
Wensing, Georg, Richard Bauer, S. Unger, G. Rohde, & Roland Heinig. (2006). Simultaneous administration of vardenafil and alcohol does not result in a pharmacodynamic or pharmacokinetic interaction in healthy male subjects. International Journal of Clinical Pharmacology and Therapeutics. 44(5). 216–224. 10 indexed citations
4.
Bauer, Richard, G. Rohde, & Prabhu Rajagopalan. (2003). Evaluation of the effects of alcohol, a high-fat breakfast, and a moderate-fat evening meal on the pharmacokinetics of the PDE5 inhibitor vardenafil. European Urology Supplements. 2(1). 176–176. 1 indexed citations
5.
Sachse, Richard, J. Hensen, G. Rohde, et al.. (2001). Vardenafil Increases Penile Rigidity and Tumescence in Men with Erectile Dysfunction after a Single Oral Dose. European Urology. 40(2). 181–190. 88 indexed citations
6.
Klotz, T., Richard Sachse, F. Jockenhövel, et al.. (2001). Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. World Journal of Urology. 19(1). 32–39. 132 indexed citations
7.
Mai, Ingrid, Lutz Fritsche, G. Rohde, et al.. (1999). Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Clinical Pharmacology & Therapeutics. 65(3). 251–261. 113 indexed citations
8.
Mück, Wolfgang, et al.. (1998). Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. European Journal of Clinical Pharmacology. 53(6). 469–473. 51 indexed citations
9.
Sachse, Richard, E. Brendel, Wolfgang Mück, et al.. (1998). Lack of drug-drug interaction between cerivastatin and nifedipine.. PubMed. 36(8). 409–13. 8 indexed citations
10.
Sachse, Richard, et al.. (1998). The effect of omeprazole pre- and cotreatment on cerivastatin absorption and metabolism in man.. PubMed. 36(10). 517–20. 4 indexed citations
11.
Hoyermann, K., et al.. (1992). Mechanisms and rates of benzoyl reactions: The reactions C6H5CHO+Cl, C6H5CO+O, and C6H5CO+H. Symposium (International) on Combustion. 24(1). 669–674. 6 indexed citations
12.
Forster, Robert J., H. Hippler, K. Hoyermann, G. Rohde, & Lawrence B. Harding. (1991). REMPI mass spectrum of the OH radical in the gas phase. Chemical Physics Letters. 183(6). 465–470. 8 indexed citations
13.
Hoyermann, K., et al.. (1990). The Reactions of the Cyclic Hydrocarbon Radicals c‐C3H5, c‐C5H9, and c‐C6H11 with O Atoms in the Gas Phase. Berichte der Bunsengesellschaft für physikalische Chemie. 94(11). 1400–1404. 8 indexed citations
14.
Hack, W., et al.. (1990). Elementary Processes of CF21B1) and CF2(X1A1) with Reactive Gases. Berichte der Bunsengesellschaft für physikalische Chemie. 94(4). 468–474. 3 indexed citations
15.
Hoyermann, K., et al.. (1989). An Experimental Study of the Reactions of CF2(X,Ã) Radicals with NO2, N2O, C2H4, C3H6 in the Gas Phase. Berichte der Bunsengesellschaft für physikalische Chemie. 93(12). 1413–1416. 14 indexed citations
16.
Rohde, G., et al.. (1986). Asymmetric distribution of purinergic and adrenergic neurotransmission cooperates in the motor activity along the rat vas deferens. Neuroscience Letters. 71(2). 197–202. 26 indexed citations
17.
Huidobro‐Toro, J. Pablo, G. Rohde, & Kazuhiko Tatemoto. (1985). Neuropeptide Y (NPY): An endogenous modulator of non-adrenergic transmission in rat vas deferens?. European Journal of Pharmacology. 109(2). 317–318. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026